Galanin: Involvement in behavior and neuropathology, and therapeutic potential

Drug News and Perspectives

Volumn 15, Issue 10, 2002, Pages 647-653

  McLaughlin, Peter J ^a   Robinson, John K ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; GALANIN RECEPTOR; LIGAND; NEUROPEPTIDE; RECEPTOR SUBTYPE;

ALZHEIMER DISEASE; ANXIETY; ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; COGNITIVE DEFECT; DENTATE GYRUS; DEPRESSION; EPILEPSY; FEEDING; HIPPOCAMPUS; LEARNING; MEMORY; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPATHY; NOCICEPTION; SEIZURE; SEXUAL BEHAVIOR;

EID: 0036977989     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2002.15.10.840020     Document Type: Article

References (87)

1. Ohtaki, T., Kumano, S. and Ishibashi, Y. et al. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J Biol Chem 1999, 274: 37041-5.
2. Tatemoto, K., Rokaeus, A., Jornvall, H., McDonald, T.J. and Mutt, V. Galanin - A novel biologically active peptide from porcine intestine. FEBS Lett 1983, 164: 124-8.
3. Ekblad, E., Arnbjornsson, E., Ekman, R., Hakanson, R. and Sundler, F. Neuropeptides in the human appendix. Distribution and motor effects. Dig Dis Sci 1989, 34: 1217-30.
4. Fox, J.E.T., McDonald, T.J., Kostolanska, F. and Tatemoto, K. Galanin: An inhibitory neuropeptide of the canine small intestine. Life Sci 1986, 39: 103-10.
5. Dunning, B.E., Ahren, B., Veith, R.C., Bottcher, G., Sundler, F. and Taborsky, G.J. Galanin: A novel pancreatic neuropeptide. Am J Physiol 1986, 251: E127-33.
6. Skofitsch, G. and Jacobowitz, D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 1985, 6: 509-46.
7. Skofitsch, G., Sills, M.A. and Jacobowitz, D.M. Autoradiographic distribution of 1251-galanin binding sites in the rat central nervous system. Peptides 1986, 7: 1029-42.
8. Melander, T., Hokfelt T. and Rokeaus, A. Distribution of galanin-like immunoreactivity in the rat central nervous system. J Comp Neurol 1986, 248: 475-517.
9. Branchek, T.A., Smith, K.E., Gerald, C. and Walker, M.W. Galanin receptor subtypes. Trends Pharmacol Sci 2000, 21: 109-17.
10. Habert-Ortoli, E., Amiranoff, B., Loquet, I., Laburthe, M. and Mayaux, J.-F. Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA 1994, 91: 9780-3.
11. Burgevin, M.-C., Loquet, I., Quarteronet, D. and Habert-Ortoli, E. Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor. J Mol Neurosci 1995, 6: 33-41.
12. O'Donnell, D., Ahmad, S., Wahlestedt, C. and Walker, P. Expression of the novel galanin receptor subtype GalR2 in the adult rat CNS: Distinct distribution from GAlR1. J Comp Neurol 1999, 409: 469-81.
13. Howard, A.D., Tan, C., Shiao, L.-L. et al. Molecular cloning and characterization of a new receptor for galanin. FEBS Lett 1997, 405: 285-90.
14. Wang, S., Hashemi, T., He, C., Strader, C. and Bayne, M. Molecular cloning and pharmacological characterization of a new galanin receptor subtype. Mol Pharmacol 1997, 52: 337-43.
15. Wang, S., He, C., Hashemi, T. and Bayne, M. Cloning and expressional characterization of a novel galanin receptor: Identification of different pharmacophores within galanin for the three galanin receptor subtypes. J Biol Chem 1997, 272: 31949-52.
16. Wang, S., Hashemi, T., Fried, S., Clemmons, A.L. and Hawes, B.E. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 1998, 37: 6711-17.
17. Xu, Z.Q., Zhang, X., Pieribone, V.A., Grillner, S. and Hokfelt, T. Galanin-5-hydroxytryptamine interactions: Electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 1998, 87: 79-94.
18. Ericson, E. and Ahlenius, S. Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic transmission. Brain Res 1999, 822: 200-9.
19. Hokfelt, T., Xu, Z.-Q.D., Shi, T.-J., Holmberg, K. and Zhang, X. Galanin in ascending systems: Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann NY Acad Sci 1998, 863: 252-63.
20. Flatters, S.J., Fox, A.J. and Dickenson, A.H. Nerve injury induces plasticity that results in spinal inhibitor effects of galanin. Pain 2002, 98: 249-58.
21. Kerr, B.J., Cafferty, W.B., Gupta, Y.K. et al. Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury. Eur J Neurosci 2000, 12: 793-802.
22. Blakeman, K.H., Holmberg, K., Hao, J.X. et al. Mice over-expressing galanin have elevated heat nociceptive threshold. Neuroreport 2001, 12: 423-5.
23. Wynick, D., Thompson, S.W. and McMahon, S.B. The role of galanin as a multi-functional neuropeptide in the nervous system. Curr Opin Pharmacol 2001, 1: 73-7.
24. Benelli, A., Arletti, R., Bertolini, A., Menozzi, B., Basaglia, R. and Poggioli, R. Galantide stimulates sexual behavior in male rats. Eur J Pharmacol 1994, 260: 279-82.
25. Park, J.J. and Baum, M.J. Intracerebroventricular infusion of the galanin antagonist M40 attenuates heterosexual partner preference in ferrets. Behav Neurosci 1999, 113: 391-400.
26. Benelli, A., Bertolini, A., Zoli, M. et al. Pharmacological manipulation of brain galaninergic system and sexual behavior in male mice. Psychopharmacol 2002, 160: 325-330.
27. Tempel, D.L., Leibowitz, K.J. and Leibowitz, S.F. Effects of PVN galanin on macronutrient selection. Peptides 1988, 9: 309-14.
28. Kyrkouli, S.E., Stanley, B.G., Seirafi, R.D. and Leibowitz, S.F. Stimulation of feeding by galanin: Anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 1990, 11: 995-1001.
29. Leibowitz, S.F., Akabayashi, A. and Wang, J. Obesity on a high-fat diet: Role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci 1998, 18: 2709-19.
30. Crawley, J.N. The role of galanin in feeding behavior Neuropeptides 1999, 33: 369-75.
31. Sahu, A. Leptin decreases food intake induced by melanin-concentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat. Endocrinology 1998, 139: 4739-42.
32. Beck, B., Stricker-Krongrad, A., Burlet, A., Cumin, F. and Burlet, C. Plasma leptin and hypothalamic neuropeptide Y and galanin levels in Long-Evans rats with marked dietary preferences. Nutr Neurosci 2001, 4: 39-50,
33. Mazarati, A., Langel, U. and Bartfai, T. Galanin: An endogenous anticonvulsant Neuroscientist 2002, 7: 506-17.
34. Mazarati, A.M., Halaszi, E. and Telegdy, G. Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res 1992, 589: 164-6.
35. Mazarati, A.M., Liu, H., Soomets, U. et al. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 1998, 18: 10070-7.
36. Bing, O., Moller, C., Engel, J.A., Soderpalm, B. and Heilig M. Anxiolytic-like action of centrally administered galanin. Neurosci Lett 1993, 164: 17-20.
37. Khoshbouei, H., Cecchi, M. and Morilak, D.A. Modulatoru effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuropsychopharmacology 2002, 27: 25-34.
38. Misane, I., Razani, H., Wang, F.H., Jansson, A., Fuxe, K. and Ogren, S.O. Modulation of a 5-HT1A receptor-mediated behavioral response by the neuropeptide galanin. Ann NY Acad Sci 1998, 863: 442-4.
39. Weiss, J.M. and Bonsall, R.W., Demetrikopoulos, M.K., Emery, M.S., West, C.H. Galanin: A significant role in deprexsion? Ann NY Acad Sci 1998, 863: 364-82.
40. Grenhoff, J., Nisell, M., Ferre, S., AstonJones, G. and Svensson, T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect 1993, 93: 11-25.
41. Consolo, S., Baldi, G., Russi, G., Civenni, G., Bartfai, T. and Vezzani, A. Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc Natl Acad Sci USA 1994, 91: 8047-51.
42. Koob, G.F., Riley, S.J., Smith, S.C. and Robbins, T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat. J Comp Physiol Psychol 1978, 92: 917-27.
43. Ungerstedt, U. Adipsia and aphagia after 6hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 1971, 367: 95-122.
44. Salamone, J.D., Steinpreis, R.E., McCullough, L.D. et al. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology 1991, 104: 515-21.
45. Hull, E.M., Weber, M.S., Eaton, R.C. et al. Dopamine receptors in the ventral tegmental area affect motor, but not motivational or reflexive, components of copulation in male rats. Brain Res 1991, 554: 72-6.
46. Pfaus, J.G. and Phillips, A.G. Role of dopamine in anticipatory and consummatory aspects of sexual behavior in the male rat. Behav Neurosci 1991, 105: 727-43.
47. Chan-Palay, V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: A hypothexis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 1988, 273: 543-57.
48. Mufson, E.J., Cochran, E., Benzing, W. and Kordower, J.H. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 1993, 4: 237-50.
49. Melander, T., Staines, W.A., Hokfelt, T. et al. Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat. Brain Res 1985, 360: 130-8.
50. Xu, Z.Q., Shi, T.J. and Hokfelt, T. Galanin/ GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J Comp Neurol 1998, 392: 227-51.
51. Hokfelt, T., Xu, Z.Q., Shi, T.J., Holmberg, K. and Zhang, X. Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann NY Acad Sci 1998, 863: 252-63.
52. Miller, M.A. Regulation of galan in memory pathways. Ann NY Acad Sci 1998, 863: 323-41.
53. Fisone, G., Wu, C.F., Consolo, S. et al. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: Histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci USA 1987, 84: 7339-43.
54. Palazzi, E., Fisone, G., Hokfelt, T., Bartfai, T. and Consolo, S. Galanin inhibits the muscarinic stimulation of phosphoinositide turnover in rat ventral hippocampus. Eur J Pharmacol 1988, 148: 479-80.
55. Sundstrom, E., Archer, T., Melander, T. and Hokfelt, T. Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim maze. Neurosci Lett 1988, 88: 331-5.
56. Ogren, S.O., Hokfelt, T., Kask, K., Langel, U. and Bartfai, T, Evidence for a role of the neuropeptide galanin in spatial learning. Neuroscience 1992, 51: 1-5.
57. Malin, D.H., Novy, B.J. and Lett-Brown. A.E. et al. Galanin attenuates retention of one-trial reward learning, Life Sci 1992, 50: 939-44.
58. Mastropaolo, J., Nadi, N.S., Ostrowski, N.L. and Crawley, J.N. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc Natl Acad Sci USA 1988, 85: 9841-5.
59. Stefani, M.R. and Gold, P.E. Intra-septal injections of glucose and glibenclamide attenuate galanin-induced spontaneous alternation performance deficits in the rat. Brain Res 1998, 813: 50-6.
60. Robinson, J.K. and Crawley, J.N. Intraventricular galanin impairs delayed nonmatching to sample performance in the rat. Behav Neurosci 1993, 107: 274-83.
61. Robinson. J.K. and Crawley, J.N. Intraseptal galanin potentiates scopolamine impairment of delayed non-matching to sample. J Neurosci 1993, 13: 5119-25.
62. Robinson, J.K. and Crawley, J.N. Analysis of anatomical sites at which galanin impairs delayed nonmatching-to-sample in rats. Behav Neurosci 1994, 108: 941-50.
63. McDonald, M.P. and Crawley, J.N. Galanin receptor antagonist M40 blocks galanininduced choice accuracy deficits on a delayed-nanmatching-to-position task. Behav Neurosci 1996, 110: 1025-32.
64. Schott, P.A., Hokfelt, T. and Ogren, S.O. Galanin and spatial learning in the rat. Evidence for a differential role for galanin in subregions of the hippocampal formation. Neuropharmacology 2000, 39: 1386-403.
65. McDonald, M.P., Wenk, G.L. and Crawley, J.N. Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin. Behav Neurosci 1997, 111: 552-63.
66. Coumis, U. and Davies, C.H. The effects of galanin on long-term synaptic plasticity in the CA1 area of rodent hippocampus. Neuroscience 2002, 112: 173-82.
67. Krzywkowski, P., Lagny-Pourmir, I., Jazat. F., Lamour, Y. and Epelbaum, J. The age-related increase in galanin binding sites in the rat brain correlates with behavioral impairment. Neurosci 1994, 59: 599-607.
68. Counts, S.E., Perez, S.E., Kahl, U. et al. Galanin: Neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. CNS Drug Rev 2001, 7: 445-70.
69. Steiner, R.A., Hohmann, J.G., Holmes, A. et al. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc Natl Acad Sci USA 2001, 98: 4184-9.
70. Kinney, J.W., Starosta, G., Holmes, A. et al. Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice. Learn Mem 2002. 9: 178-90.
71. Hokfelt, T., Millhorn, D., Seroogy, K. et al. Coexistence of peptides with classical neurotransmitters. Experientia 1987, 43: 768-80.
72. Bartfai, T. Galanin: A neuropeptide with important central nervous system actions. In: Psychopharmacology: The Fourth Generation of Progress. F.E. Bloom and D.J. Kupfer (Eds.). Raven Press: New York, 1995, p. 563.
73. BIOTECH Patent News, http://www. biotechpatent.com, August 1, 1997.
74. PR Newswire, http://www.prnewswire. com/, May 14, 1999.
75. Bartfai, T., Fisone, G. and Langel. U. Galanin and galanin antagonists-Molecular and biochemical perspectives. Trends Pharmacol Sci 1992, 13: 312-7.
76. Langel, U., Land, T. and Bartfai, T. Design of chimeric peptide ligands to galanin receptors and substance P receptors. Int J Pept Protein Res 1992, 39: 516-22.
77. Bartfai, T., Bedecs, K., Land, T. et al. M-15: High-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Natl Acad Sci USA 1991, 88: 10961-5.
78. Crawley, J.N., Robinson, J.K., Langel, U. and Bartfai, T. Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res 1993, 600: 268-72.
79. Lindskog, S., Ahren, B., Land, T., Langel, U. and Bartfai, T. The novel high-affinity antagonist, galantide blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol 1992, 210: 183-8.
80. McDonald, M.P., Willard, L.B., Wenk, G.L. and Crawley, J.N. Coadministration of galanin antagonist M40 with a muscarinic MI agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions. J Neurosci 1998, 18: 5078-85.
81. Chu, M.M., Truumees, R. et al. A new fungal metabolite, SCH 202596, with inhibitory activity in the galanin receptor GalR1 assay. Tetrahedron Lett 1997, 38: 6111-4.
82. Scott, M.K., Ross, T.M., Lee, D.H. et al. 2,3-Dihydro-dithiin and -dithiepine-1, 4, 4-tetroxides: Small molecule non-peptide antagonists of the human galanin hGAL-1 receptor. Bioorg Med Chem 2000, 8: 1383-91.
83. Saar, K., Mazarati, A.M., Mahlapuu, R. et al. Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci USA 2002, 99: 7136-41.
84. Floren, A., Land, T. and Langel, U. Galanin receptor subtypes and ligand binding. Neuropeptides 2000, 34: 331-7.
85. Ji, R.-R., Zhang, Q., Bedecs, K. et al. Galanin antisense oligonucleotides reduce galanin levels in dorsal root ganglia and induce autotomy in rats after axotomy. Proc Natl Acad Sci USA 1994, 91: 12540-3.
86. Pooga, M., Soomets, U., Hallbrink, M. et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 1998, 16: 857-61.
87. Hallbrink, M., Floren, A., Elmquist, A., Pooga, M., Bartfai, T. and Langel, U. Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta 2001, 1515: 101-9.